Two new isospirostanol-type saponins derived from the bulbs of Lilium brownii and their anti-hepatocarcinogenic activity.

Apoptosis Hepatocellular carcinoma Isospirostanol-type saponin Lilium brownii

Journal

Chemistry & biodiversity
ISSN: 1612-1880
Titre abrégé: Chem Biodivers
Pays: Switzerland
ID NLM: 101197449

Informations de publication

Date de publication:
27 Feb 2024
Historique:
revised: 21 02 2024
received: 30 01 2024
accepted: 27 02 2024
medline: 28 2 2024
pubmed: 28 2 2024
entrez: 28 2 2024
Statut: aheadofprint

Résumé

Bulbs ofLilium brownii, commonly known as "Bai-he" in China, serve both edible and medicinal purposes in clinical practice. In this study, two new isospirostanol-type saponins were isolated from L. brownii, and their structures were identified by spectroscopic method, and absolute configurations were elucidated by comprehensive analysis of spectral data obtained from combined acid hydrolysis. Two compounds were finally identified as 3-O-[α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside]-(22R,25R)-5α-spirosolane-3β-ol (1) and 3-O-{α-L-rhamnopyranosyl-(1→2)-[β-D-glucopyranosyl-(1→4)]-β-D-glucopyranoside}-(22R,25R)-5α-spirosolane-3β-ol (2), respectively. Further, we found that compound 2 significantly suppressed the proliferation of SMMC-7721 and HepG2 cells with IC50 values of 26.3±1.08 µM and 30.9±1.59 µM, whereas compound 1 didn't inhibit both of the two hepatocellular carcinoma. Subsequently, compound 2 effectively decreased the levels of interleukin-1β and tumor necrosis factor-α and the expression of Bcl-2, and increased the expression of Bax and Caspase-3 proteins. Which indicated that the anti-hepatocellular carcinoma effect of compound 2 involves reducing the level of inflammation and inducing apoptosis.

Identifiants

pubmed: 38414116
doi: 10.1002/cbdv.202400257
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202400257

Informations de copyright

© 2024 Wiley-VCH GmbH.

Auteurs

Shuaibo He (S)

Henan University of Chinese Medicine, Department of Pharmacy, NO156 Jinshui East Road, Zhengzhou, 450046, Zhengzhou, CHINA.

Tingjuan Wu (T)

Henan University of Chinese Medicine, Department of Pharmacy, NO156 Jinshui East Road, Zhengzhou, 450046, Zhengzhou, CHINA.

Yanpo Si (Y)

Henan University of Chinese Medicine, Department of Pharmacy, NO156 Jinshui East Road, Zhengzhou, 450046, Zhengzhou, CHINA.

Jihong Kang (J)

Dingxi City People's Hospital, Pharmacy Department, No.22, Anding Road, Anding District, Dingxi City, Dingxi, CHINA.

Wenjun Wei (W)

Henan University of Chinese Medicine, Department of Pharmacy, NO156 Jinshui East Road, Zhengzhou, 450046, Zhengzhou, CHINA.

Fei Zhang (F)

Henan University of Chinese Medicine, Department of Pharmacy, NO156 Jinshui East Road, Zhengzhou, 450046, Zhengzhou, CHINA.

Shuying Feng (S)

Henan University of Chinese Medicine, Medical College, NO156 Jinshui East Road, Zhengzhou, 450046, Zhengzhou, CHINA.

Jianping Ma (J)

Lanzhou University of Technology, School of Life Sciences and Engineering, No. 287, Langongping, Qilihe District, Lanzhou City, China, 730050, Lanzhou, CHINA.

Ya Wang (Y)

Lanzhou University of Technology, School of Life Sciences and Engineering, No. 287, Langongping, Qilihe District, Lanzhou City, China, 730050, Lanzhou, CHINA.

Tao Guo (T)

Henan University of Chinese Medicine, Department of Pharmacy, NO 156 Jinshui East Road, Zhengzhou, Henan Province, China, 450046, Zhengzhou, CHINA.

Classifications MeSH